InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) Institutional Ownership

CUSIP: 457637601

13F Institutional Holders and Ownership History from Q3 2022 to Q1 2025

Type / Class
Equity / Common Shares, no par value
Symbol
INM on Nasdaq
Shares outstanding
804,525
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 10% $14,885 80,372 YA II PN, Ltd. 13 Dec 2024

Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$5 0
2024 Q4 0 $0 -$265,983 0
2024 Q3 1,141,865 $265,983 +$152,049 $0.24 12
2024 Q2 440,244 $116,623 -$95,797 $0.27 10
2024 Q1 685,852 $249,191 -$42,696 $0.36 14
2023 Q4 804,163 $334,349 +$315,907 $0.42 13
2023 Q3 26,865 $18,551 +$7,235 $0.69 8
2023 Q2 15,650 $14,412 -$91,568 $0.92 7
2023 Q1 100,918 $109,292 -$123,996 $1.08 12
2022 Q4 115,828 $234,169 -$203,650 $2.00 11
2022 Q3 132,993 $876,125 +$876,125 $6.58 8